Last year in October, Sun Pharma had recalled 747 bottles of generic diabetes drug in the US due to the possibility of the affected lot containing cancer-causing nitrosodimethylamine.
Sun Pharma recalls 36,275 cartons of testosterone injection in US
As per the USFDA report, the affected lot of the intramuscular injections was manufactured by the drug maker in India and distributed in the US by Princeton, New Jersey-based Sun Pharmaceutical Industries Inc.
BusinessToday.In | February 7, 2021 | Updated 16:35 IST
Sun Pharmaceutical Industries is recalling 36,275 cartons of Testosterone Cypionate Injection
Pharma major Sun Pharmaceutical Industries is recalling 36,275 cartons of a drug used to treat low testosterone levels in the US market for incorrect labelling. The Testosterone Cypionate Injection is being recalled in the American market by the US arm of Sun Pharma, as per the latest enforcement report of the US Food and Drug Administration. The company started the nationwide recall on January 11, 2021.
The US arm of the domestic pharma major is recalling Testosterone Cypionate Injection in the American market, according to the latest enforcement report of the US Food and Drug Administration.
Lupin Soars Over 2% On Getting Nod For Bacterial Infection Medications Lupin Soars Over 2% On Getting Nod For Bacterial Infection Medications Sulfamethoxazole and Trimethoprim Oral Suspension USP is indicated for treating and preventing a variety of bacterial infections, such as middle ear, urine, respiratory, and intestinal infections
Updated: January 07, 2021 10:29 am IST
At 10:25 am, the shares of Lupin were trading at Rs 101.30, up 0.35 per cent on the BSE.
Lupin shares edged higher in early trading after the pharma company, on Wednesday, received approval from the United States Food and Drug Administration (USFDA) for its Sulfamethoxazole and Trimethoprim Oral Suspension USP, 200 mg/40 mg per 5 ml, to market a generic equivalent of Bactrim Oral Suspension, 200 mg/40 mg per 5 mL, of Sun Pharmaceutical Industries, Inc. The shares of Lupin touched an intra-day high of Rs 1,025, up 2.4 per cent in early trading, and at 10:25 am, the shares were trading at Rs 101.30, up 0.35
Stocks To Watch: Dixon Technologies, Sobha Ltd, Lupin, Bandhan Bank, NMDC The domestic stock markets are likely to open in the green after a day s paused due to positive cues from across the global markets.
Updated: January 07, 2021 10:03 pm IST
The domestic stock markets are likely to open in the green after a day s paused due to positive cues from across the global markets. Asian markets are looking up in early trading, Wall Street had a firm closing and early trends on SGX Nifty indicate a positive opening for the index in India, with a 74-points gain. At 7:30 am, the Nifty futures were trading at 14,254, higher by 74 points or 0.67 per cent on the Singapore Stock Exchange.